Fate Therapeutics Inc (FATE)
3.75
+0.16
(+4.46%)
USD |
NASDAQ |
Jun 21, 16:00
3.76
+0.01
(+0.27%)
After-Hours: 20:00
Fate Therapeutics Net Income (Annual): -160.93M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -160.93M |
| December 31, 2022 | -281.72M |
| December 31, 2021 | -212.15M |
| December 31, 2020 | -173.39M |
| December 31, 2019 | -98.15M |
| December 31, 2018 | -66.60M |
| December 31, 2017 | -42.95M |
| Date | Value |
|---|---|
| December 31, 2016 | -33.46M |
| December 31, 2015 | -29.99M |
| December 31, 2014 | -25.88M |
| December 31, 2013 | -20.89M |
| December 31, 2012 | -14.24M |
| December 31, 2011 | -13.43M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-281.72M
Minimum
2022
-98.15M
Maximum
2019
-185.27M
Average
-173.39M
Median
2020
Net Income (Annual) Benchmarks
| Amicus Therapeutics Inc | -151.58M |
| Ocular Therapeutix Inc | -80.74M |
| AnaptysBio Inc | -163.62M |
| Stoke Therapeutics Inc | -104.70M |
| Olema Pharmaceuticals inc | -96.66M |